◆ NeutralMCK
McKesson (MCK) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research·
McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy) rating due to upward trends in earnings estimates. The prescription drug distributor's Zacks Consensus Estimate has increased 1.5% over the past three months, positioning it in the top 20% of Zacks-covered stocks for estimate revisions. The upgrade suggests potential near-term stock price appreciation based on improving business fundamentals.
Read Full Article at Zacks Investment Research →